FY2026 EPS Estimates for Transcat Lowered by Northland Capmk

Transcat, Inc. (NASDAQ:TRNS) – Investment analysts at Northland Capmk lowered their FY2026 EPS estimates for shares of Transcat in a research note issued on Monday, December 16th. Northland Capmk analyst E. Jackson now expects that the scientific and technical instruments company will earn $1.92 per share for the year, down from their previous forecast of $2.42. The consensus estimate for Transcat’s current full-year earnings is $1.76 per share. Northland Capmk also issued estimates for Transcat’s FY2027 earnings at $2.19 EPS, FY2028 earnings at $2.50 EPS and FY2029 earnings at $2.86 EPS.

Transcat (NASDAQ:TRNS) last issued its quarterly earnings data on Monday, October 28th. The scientific and technical instruments company reported $0.35 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.12). The business had revenue of $67.83 million for the quarter, compared to analyst estimates of $70.30 million. Transcat had a return on equity of 7.36% and a net margin of 6.63%. The firm’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same period in the previous year, the business posted $0.41 earnings per share.

Several other research firms have also issued reports on TRNS. Oppenheimer reissued an “outperform” rating and set a $130.00 target price (down previously from $155.00) on shares of Transcat in a research note on Wednesday, October 30th. Northland Securities reduced their target price on shares of Transcat from $130.00 to $110.00 and set a “market perform” rating on the stock in a report on Wednesday, October 30th. HC Wainwright reissued a “buy” rating and issued a $156.00 target price on shares of Transcat in a report on Tuesday, October 29th. Craig Hallum boosted their price objective on shares of Transcat from $113.00 to $125.00 and gave the stock a “buy” rating in a research report on Thursday, December 12th. Finally, StockNews.com cut Transcat from a “hold” rating to a “sell” rating in a research report on Tuesday, October 29th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $130.25.

Transcat Price Performance

Shares of TRNS stock traded up $1.86 during trading hours on Thursday, hitting $105.85. The company had a trading volume of 10,854 shares, compared to its average volume of 55,007. The stock has a market capitalization of $973.71 million, a PE ratio of 53.46 and a beta of 0.70. The company’s fifty day moving average is $110.56 and its 200 day moving average is $118.95. Transcat has a fifty-two week low of $94.29 and a fifty-two week high of $147.12.

Institutional Trading of Transcat

Hedge funds have recently modified their holdings of the business. Virtu Financial LLC boosted its position in shares of Transcat by 127.0% during the 3rd quarter. Virtu Financial LLC now owns 4,136 shares of the scientific and technical instruments company’s stock worth $499,000 after purchasing an additional 2,314 shares in the last quarter. Geode Capital Management LLC grew its position in Transcat by 5.4% during the third quarter. Geode Capital Management LLC now owns 217,473 shares of the scientific and technical instruments company’s stock worth $26,269,000 after buying an additional 11,106 shares during the period. Barclays PLC increased its holdings in Transcat by 393.0% in the third quarter. Barclays PLC now owns 15,130 shares of the scientific and technical instruments company’s stock valued at $1,826,000 after buying an additional 12,061 shares in the last quarter. State Street Corp lifted its position in shares of Transcat by 8.1% during the 3rd quarter. State Street Corp now owns 207,230 shares of the scientific and technical instruments company’s stock valued at $25,027,000 after acquiring an additional 15,514 shares during the period. Finally, Needham Investment Management LLC boosted its stake in shares of Transcat by 43.6% during the 3rd quarter. Needham Investment Management LLC now owns 39,500 shares of the scientific and technical instruments company’s stock worth $4,770,000 after acquiring an additional 12,000 shares in the last quarter. 98.34% of the stock is owned by institutional investors and hedge funds.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.